Century Therapeutics (IPSC) Prepaid Assets (2020 - 2026)
Century Therapeutics (IPSC) posted quarterly Prepaid Assets of $4.2 million for Q1 2026, down 6.08% year-over-year from $4.5 million in Q1 2025, and up 15.9% quarter-over-quarter from $3.7 million in Q4 2025.
Analysis
Century Therapeutics (IPSC) Prepaid Assets (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has reported Prepaid Assets for 7 consecutive years, with $4.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 6.08% year-over-year to $4.2 million; the TTM figure through Mar 2026 stood at $4.2 million (down 6.08% YoY), while the FY2025 annual figure was $3.7 million, up 975.0% from the prior year.
- Prepaid Assets grew to $4.2 million in Q1 2026 per IPSC's latest filing, from $3.7 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $7.9 million in Q3 2024 and bottomed at $34000.0 in Q4 2023.
- Historically, Prepaid Assets has averaged $3.4 million across 5 years, with a median of $3.7 million in 2022.
- Annual changes were most pronounced in 2023 — Prepaid Assets sank 97.66% — and 2025, when it soared 975.0%.
- Century Therapeutics' Prepaid Assets stood at $1.5 million in 2022, then tumbled by 97.66% to $34000.0 in 2023, then surged by 900.0% to $340000.0 in 2024, then jumped by 975.0% to $3.7 million in 2025, then rose by 15.9% to $4.2 million in 2026.
- Business Quant data shows IPSC's Prepaid Assets at $4.2 million in Q1 2026, $3.7 million in Q4 2025, and $5.0 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Century Therapeutics | 440.37 Mn | 180.29 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.06 Mn |
| Mar 31, 2026 | 4.24 Mn |
| Dec 31, 2025 | 3.66 Mn |
| Sep 30, 2025 | 4.96 Mn |
| Jun 30, 2025 | 4.33 Mn |
| Mar 31, 2025 | 4.51 Mn |
| Dec 31, 2024 | 4.76 Mn |
| Sep 30, 2024 | 7.90 Mn |
| Jun 30, 2024 | 7.08 Mn |
| Mar 31, 2024 | 7.80 Mn |
| Dec 31, 2023 | 4.26 Mn |
| Sep 30, 2023 | 4.20 Mn |
| Jun 30, 2023 | 4.88 Mn |
| Mar 31, 2023 | 4.47 Mn |
| Dec 31, 2022 | 4.00 Mn |
| Sep 30, 2022 | 5.44 Mn |
| Jun 30, 2022 | 4.56 Mn |
| Mar 31, 2022 | 3.74 Mn |
| Dec 31, 2021 | 4.77 Mn |
| Sep 30, 2021 | 4.74 Mn |